Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile

Journal of Controlled Release

Volumn 105, Issue 1-2, 2005, Pages 68-76

  Ishihara, Tsutomu ^a   Izumo, Nobuo ^a   Higaki, Megumu ^b   Shimada, Emi ^a   Hagi, Tomomi ^a   Mine, Lisa ^b   Ogawa, Yasuaki ^b   Mizushima, Yutaka ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nanoparticles; PLA; PLGA; Sustained release; Zinc

Indexed keywords

CARBOXYLIC ACIDS; CONCENTRATION (PROCESS); DERIVATIVES; DIFFUSION; MOLECULAR WEIGHT; PHOSPHATES; SOLUBILITY; SURFACE ACTIVE AGENTS;

BETAMETHASONE; CORTICOSTEROID DERIVATIVES; MURINE MACROPHAGES; POLY(D,1-LACTIC ACID) (PLA);

NANOSTRUCTURED MATERIALS;

BETAMETHASONE; NANOPARTICLE; POLYGLACTIN; POLYLACTIC ACID; SURFACTANT; ZINC;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PRODUCTIVITY; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CAPSULES; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; LACTIC ACID; MACROPHAGES; METALS; MICE; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; ZINC;

EID: 20444416369     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.02.026     Document Type: Article

References (21)

1. J.H. Senior Fate and behavior of liposomes in vivo: a review of controlling factors CRC Crit. Rev. Ther. Drug Carrier Syst. 3 1987 123 193
2. S.J. Douglas, S.S. Davis, and L. Illum Nanoparticles in drug delivery CRC Crit. Rev. Ther. Drug Carrier Syst. 3 1987 233 261
3. Y. Mizushima, T. Hamano, and K. Yokoyama Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion Ann. Rheum. Dis. 41 1982 263 267
4. Y. Mizushima, T. Hamano, and K. Yokoyama Use of a lipid emulsion as a novel carrier for corticosteroids J. Pharm. Pharmacol. 34 1982 49 50
5. H. Okada One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Adv. Drug Deliv. Rev. 28 1997 43 70
6. H. Okada, Y. Doken, Y. Ogawa, and H. Toguchi Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers Pharm. Res. 11 1994 1143
7. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior J. Control. Release 25 1993 89 98
8. Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods Eur. J. Pharm. Biopharm. 45 1998 41 48
9. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method Int. J. Pharm. 187 1999 143 152
10. E. Horisawa, T. Hirota, S. Kawazoe, J. Yamada, H. Yamamoto, H. Takeuchi, and Y. Kawashima Prolonged anti-inflammatory action of dl-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit Pharm. Res. 19 2002 403 410
11. S.P. Schwendeman Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems Crit. Rev. Ther. Drug Carr. Syst. 19 2002 73 98
12. X.M. Lam, E.T. Duenas, and J.L. Cleland Encapsulation and stabilization of nerve growth factor into poly(lactide-co-glycolic) acid microspheres J. Pharm. Sci. 90 2001 1356 1365
13. G.P. Carino, J.S. Jacob, and E. Mathiowitz Nanosphere based oral insulin delivery J. Control. Release 65 2000 261 269
14. X.M. Lam, E.T. Duenas, A.L. Daugherty, N. Levin, and J.L. Cleland Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes J. Control. Release 67 2000 281 292
15. Y. Yamagata, M. Misaki, T. Kurokawa, K. Taira, and S. Takada Preparation of a copoly(dl-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone Int. J. Pharm. 251 2003 133 141
16. G. Zhu, S.R. Mallery, and S.P. Schwendeman Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide) Nat. Biotechnol. 18 2000 52 57
17. M.A. Tracy, K.L. Ward, L. Firouzabadian, Y. Wang, N. Dong, R. Qian, and Y. Zhang Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro Biomaterials 20 1999 1057 1062
18. X. Zhang, S. Zale, L. Sawyer, and H. Bernstein Effects of metal salts on poly(dl-lactide-co-glycolide) polymer hydrolysis J. Biomed. Mater. Res. 34 1997 531 538
19. L.C. Makala, Y. Nishikawa, T. Kamada, H. Suzuki, X. Xuan, I. Igarashi, and H. Nagasawa Comparison of the accessory activity of murine peritoneal cavity macrophage derived dendritic cells and peritoneal cavity macrophages in a mixed lymphocyte reaction J. Vet. Med. Sci. 63 2001 1271 1277
20. H. Okada, M. Yamamoto, T. Heya, Y. Inoue, S. Kamei, Y. Ogawa, and H. Toguchi Drug delivery using biodegradable microspheres J. Control. Release 28 1994 121 129
21. M.E. Lutsiak, D.R. Robinson, C. Coester, G.S. Kwon, and J. Samuel Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro Pharm. Res. 10 2002 1480 1487